J. Goldman & Co »

Nektar Therapeutics shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $776k 18k 42.28

More positions owned by J. Goldman & Co

Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Honeywell International (HON)
Comcast Corp Cl A (CMCSA)
Western Union Company (WU)
Apple Call Option (AAPL)
Aramark Hldgs (ARMK)
Centuri Holdings Com Shs (CTRI)
Amazon (AMZN)
Gap (GAP)
eBay (EBAY)
Boeing Company (BA)
Sentinelone Cl A (S)
Verra Mobility Corp Cl A Com Stk (VRRM)

View all positions for J. Goldman & Co

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics